# Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Canonical URL: https://biopharmsignal.com/news/FATE/fate-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-and-business-updates
Ticker: FATE
Company: Fate Therapeutics
Source: Fate Therapeutics
Published: 2026-02-26 14:00 EST
Original Source URL: https://ir.fatetherapeutics.com
## Summary

Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as same-day hospital discharge Four systemic sclerosis patients and the first idiopathic inflammatory myopathy patient treated with FT819; First systemic

## Article Body
Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as same-day hospital discharge Four systemic sclerosis patients and the first idiopathic inflammatory myopathy patient treated with FT819; First systemic
## Recent Company News
- 2026-07-09 12:30 EST — [Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate](https://biopharmsignal.com/news/FATE/fate-therapeutics-receives-fda-clearance-of-investigational-new-drug-application-5f43a8db) — Source: Fate Therapeutics
- 2026-07-06 12:30 EST — [Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting](https://biopharmsignal.com/news/FATE/fate-therapeutics-to-present-preliminary-clinical-data-of-ft819-off-the-shelf-ca-2ca1e01e) — Source: Fate Therapeutics
- 2026-07-01 20:05 EST — [Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences](https://biopharmsignal.com/news/FATE/fate-therapeutics-to-participate-in-upcoming-third-quarter-2026-conferences-457e2808) — Source: Fate Therapeutics
- 2026-06-15 12:30 EST — [Fate Therapeutics Appoints Laura Hamill to Board of Directors](https://biopharmsignal.com/news/FATE/fate-therapeutics-appoints-laura-hamill-to-board-of-directors-d47c62a6) — Source: Fate Therapeutics
- 2026-06-04 12:30 EST — [Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting](https://biopharmsignal.com/news/FATE/fate-therapeutics-showcases-data-from-ft819-and-ft839-programs-at-the-european-c-c6edd4ee) — Source: Fate Therapeutics
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)